Intravenous Dexamethsone
Hip Pain Chronic
Poznan University of Medical SciencesPhase 4 / ApprovedActive
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Hip Pain Chronic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ROPIVACAINE Poznan University of Medical Sciences | Phase 4 | BBB |
DEXAMETHASONE Poznan University of Medical Sciences | Phase 4 | BB |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Kocaeli University | Phase 4 | BB |
Bxcl501 Poznan University of Medical Sciences | Phase 4 | BB |
Tranexamic Acid Northwestern University | Phase 3 | B |
View all 11 →
Same molecule, other indications
Intravenous Dexamethsone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →